Twelve metabolites of the synthetic cannabinoid, EAM-2201, have been tentatively identified in human hepatocytes in vitro, As well as in human liver and urine specimens in vivo for the first time. Possible metabolites on the cannabimimetic agent JWH-018 had been synthesised, characterised to probe for their in vivo era and https://hemalchem.com/product-category/am-series/